Phase I/II Study of PEGylated Arginine Deiminase (ADI-PEG20) With Carboplatin and Cabazitaxel in Men With Aggressive Variant Prostate Cancers (AVPC)
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Astellas Pharma Inc
Janssen Research & Development, LLC
Astellas Pharma Inc
Neonc Technologies, Inc.
AstraZeneca
Merck Sharp & Dohme LLC
Maastricht University Medical Center
City of Hope Medical Center
Nektar Therapeutics
Xennials Therapeutics Australia Pty Ltd
University of Washington
M.D. Anderson Cancer Center
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Valerio Therapeutics
Memorial Sloan Kettering Cancer Center
Temple University